UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma

Frontiers in oncology, 2021-04, Vol.11, p.679177

2021

Link zum Volltext

Verfügbarkeit prüfen

Advanced Bladder Cancer Rechallenged With an Immune Checkpoint Inhibitor: A Case Report

Urology (Ridgewood, N.J.), 2019-09, Vol.131, p.24-26

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II trial of pazopanib alternating with bevacizumab in treatment-naïve metastatic clear cell renal cell carcinoma (CCRCC) patients: Phase I results

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.561-561

2019

Link zum Volltext

Verfügbarkeit prüfen

Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer: Emerging Treatment Paradigms

Journal of the National Comprehensive Cancer Network, 2015-07, Vol.13 (7), p.e49

2015

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma

Frontiers in oncology, 2021, Vol.11, p.679177-679177

2021

Link zum Volltext

Verfügbarkeit prüfen

Small-Cell Lung Cancer: Prognostic Factors and Changing Treatment Over 15 Years

Clinical lung cancer, 2012-03, Vol.13 (2), p.115-122

2012

Link zum Volltext

Verfügbarkeit prüfen

Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis

The Journal of immunology (1950), 2016-02, Vol.196 (4), p.1541-1549

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase I–IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1815-1824

2013

Link zum Volltext

Verfügbarkeit prüfen

Limited-Stage Small-Cell Lung Cancer (Stages I-III): Observations from the National Cancer Data Base

Clinical lung cancer, 2005-05, Vol.6 (6), p.355-360

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1538: Levels and enzyme activity of CD73 in primary samples from cancer patients

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1538-1538

2015

Link zum Volltext

Verfügbarkeit prüfen

Summary Report 7th Annual Targeted Therapies of the Treatment of Lung Cancer

Journal of thoracic oncology, 2008-05, Vol.3 (5), p.545-555

2008

Link zum Volltext

Verfügbarkeit prüfen

Tumor regression and pharmacodynamic (PD) biomarker validation in non-small cell lung cancer (NSCLC) patients treated with the ErbB/VEGFR inhibitor BMS-690514

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8098-8098

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase I multicenter trial of BMS-690514: Safety, pharmacokinetic profile, biological effects, and early clinical evaluation in patients with advanced solid tumors and non-small cell lung cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2564-2564

2008

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapy

Clinical lung cancer, 2005-12, Vol.7 Suppl 3, p.S93-S97

2005

Link zum Volltext

Verfügbarkeit prüfen

Summary of Selected Presentations from the 8th Annual Targeted Therapy in Lung Cancer Symposium

Journal of thoracic oncology, 2009-07, Vol.4 (7), p.930-935

2009

Link zum Volltext

Verfügbarkeit prüfen

392 POSTER A phase I/II multicenter trial of BMS-690514, an ErbB-VEGFR inhibitor, in patients with advanced NSCLC who are erlotinib naive or previously treated with erlotinib

European journal of cancer supplements, 2008, Vol.6 (12), p.123-123

2008

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Strategies for Combined-Modality Therapy of Locally Advanced-Stage Non–Small-Cell Lung Cancer: Rationale for Consolidation Docetaxel Therapy

Clinical lung cancer, 2005-12, Vol.7, p.S93-S97

2005

Link zum Volltext

Verfügbarkeit prüfen

Personality Processes and Problem Behavior

Journal of personality, 2000-12, Vol.68 (6), p.953-966

Hoyle, Rick H.

2000

Link zum Volltext

Verfügbarkeit prüfen

Preface

Quaestiones mathematicae, 1992-07, Vol.15 (3), p.i-i

1992

Link zum Volltext

Verfügbarkeit prüfen

Preface

Quaestiones mathematicae, 1992-07, Vol.15 (3), p.i-i

1992

Link zum Volltext

Verfügbarkeit prüfen

Parabolic Equations with Dominating Convection Terms

Numerical Solution of Partial Differential Equations: Theory, Tools and Case Studies, p.185-203

Link zum Volltext

Verfügbarkeit prüfen

Book Reviews

The European Legacy: Theatre as Storytelling, 2008, Vol.13 (3), p.351-396

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Female
(5)
Life Sciences & Biomedicine
(5)
Male
(5)
Science & Technology
(5)
Aged
(4)
Lung Neoplasms - Therapy
(4)
Middle Aged
(4)
Oncology
(4)
Adult
(3)
Hematology, Oncology And Palliative Medicine
(3)
Lung Neoplasms - Mortality
(3)
Lung Neoplasms - Pathology
(3)
Carcinoma, Non-Small-Cell Lung - Pathology
(2)
Combined Modality Therapy
(2)
Lung Cancer
(2)
Lung Neoplasms - Drug Therapy
(2)
Neoplasm Staging
(2)
Adenocarcinoma - Drug Therapy
(1)
Administration, Oral
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma

Advanced Bladder Cancer Rechallenged With an Immune Checkpoint Inhibitor: A Case Report

A phase I/II trial of pazopanib alternating with bevacizumab in treatment-naïve metastatic clear cell renal cell carcinoma (CCRCC) patients: Phase I results

Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer: Emerging Treatment Paradigms

Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma

Small-Cell Lung Cancer: Prognostic Factors and Changing Treatment Over 15 Years

Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis

Phase I–IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours

Limited-Stage Small-Cell Lung Cancer (Stages I-III): Observations from the National Cancer Data Base

Abstract 1538: Levels and enzyme activity of CD73 in primary samples from cancer patients

Summary Report 7th Annual Targeted Therapies of the Treatment of Lung Cancer

Tumor regression and pharmacodynamic (PD) biomarker validation in non-small cell lung cancer (NSCLC) patients treated with the ErbB/VEGFR inhibitor BMS-690514

Phase I multicenter trial of BMS-690514: Safety, pharmacokinetic profile, biological effects, and early clinical evaluation in patients with advanced solid tumors and non-small cell lung cancer

Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapy

Summary of Selected Presentations from the 8th Annual Targeted Therapy in Lung Cancer Symposium

392 POSTER A phase I/II multicenter trial of BMS-690514, an ErbB-VEGFR inhibitor, in patients with advanced NSCLC who are erlotinib naive or previously treated with erlotinib

Therapeutic Strategies for Combined-Modality Therapy of Locally Advanced-Stage Non–Small-Cell Lung Cancer: Rationale for Consolidation Docetaxel Therapy

Personality Processes and Problem Behavior

Preface

Preface

Parabolic Equations with Dominating Convection Terms

Book Reviews

Book Reviews

Suchergebnisse filtern